We are live on ! Find out more
ETON icon

Eton Pharmaceutcials
ETON

14 hedge funds and large institutions have $14.4M invested in Eton Pharmaceutcials in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

40% more funds holding

Funds holding: 10 → 14 (+4)

2.8% more ownership

Funds ownership: 10.03% → 12.82% (+2.8%)

3% more capital invested

Capital invested by funds: $14M → $14.4M (+$428K)

Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.46M
2
OM
Opaleye Management
Massachusetts
+$574K
3
AIC
AWM Investment Company
New York
+$373K
4
FAAS
First Allied Advisory Services
California
+$231K
5
First Trust Advisors
First Trust Advisors
Illinois
+$157K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$11.7K
2
UBS Group
UBS Group
Switzerland
-$9K
Name Holding Trade Value Shares
Change 		Change in
Stake
OM
1
Opaleye Management
Massachusetts
$7.36M +$574K +90,000 +8%
AIC
2
AWM Investment Company
New York
$3.06M +$373K +58,466 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.63M +$1.46M +228,788 +795%
DC
4
Diametric Capital
Massachusetts
$1.03M +$118K +18,540 +13%
PCM
5
Prelude Capital Management
New York
$467K +$115K +18,047 +32%
BlackRock
6
BlackRock
New York
$233K +$69.2K +10,844 +42%
FAAS
7
First Allied Advisory Services
California
$228K +$231K +36,146 New
First Trust Advisors
8
First Trust Advisors
Illinois
$155K +$157K +24,581 New
Northern Trust
9
Northern Trust
Illinois
$135K +$137K +21,393 New
Wells Fargo
10
Wells Fargo
California
$38K – – –
Morgan Stanley
11
Morgan Stanley
New York
$32K +$17.9K +2,800 +124%
Victory Capital Management
12
Victory Capital Management
Texas
$13K +$13.6K +2,127 New
TRCT
13
Tower Research Capital (TRC)
New York
$8K -$11.7K -1,832 -58%
Royal Bank of Canada
14
Royal Bank of Canada
Ontario, Canada
$7K +$7.06K +1,106 New
UBS Group
15
UBS Group
Switzerland
– -$9K -1,189 Closed

ETON Hedge Fund Activity: Q3 2019 in Review

14 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q3 2019, worth a combined $14.4M — up 3.1% from $14M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ETON positions and 1 closed out — a net gain of 4 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.46M. The largest seller was Tower Research Capital (TRC), cutting an estimated $11.7K.

  • 14 institutional investors held Eton Pharmaceutcials (ETON) as of Q3 2019, up from 10 in Q2 2019.
  • Funds reported $14.4M of Eton Pharmaceutcials stock for Q3 2019, up 3.1% quarter-over-quarter.
  • 5 funds opened new Eton Pharmaceutcials positions in Q3 2019 and 1 closed out, a net change of +4 holders.
  • The largest Eton Pharmaceutcials buyer in Q3 2019 was Vanguard Group, an estimated $1.46M added.
  • The largest Eton Pharmaceutcials seller in Q3 2019 was Tower Research Capital (TRC), an estimated $11.7K sold.

Based on aggregated 13F filings for Q3 2019.